ES2168378T3 - Determinacion de tripsinogeno-2 libre y en forma de complejo. - Google Patents

Determinacion de tripsinogeno-2 libre y en forma de complejo.

Info

Publication number
ES2168378T3
ES2168378T3 ES95929116T ES95929116T ES2168378T3 ES 2168378 T3 ES2168378 T3 ES 2168378T3 ES 95929116 T ES95929116 T ES 95929116T ES 95929116 T ES95929116 T ES 95929116T ES 2168378 T3 ES2168378 T3 ES 2168378T3
Authority
ES
Spain
Prior art keywords
pct
trypsin
trypsinogen
free
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95929116T
Other languages
English (en)
Inventor
Ulf-Hakan Stenman
Johan Hedstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2168378T3 publication Critical patent/ES2168378T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UN INMUNOENSAYO PARA EL TRIPSINOGENO2 EN EL QUE SE MIDE UNA CANTIDAD DE ANALITO EN UNA MUESTRA, EL ANALITO ES BIEN TRIPSINA-2 COMPLEJADA CON ALFA-1-ANTITRIPSINA (TRIPSINA-2-AAT) EN EL SUERO, O BIEN TRIPSINOGENO-2 EN LA ORINA. DE ACUERDO CON UNA REALIZACION PREFERIDA, EL COMPLEJO DE TRIPSINA-2-AAT O EL TRIPSINOGENO-2 LIBRE SE MIDEN MEDIANTE METODOS NO COMPETITIVOS QUE EMPLEAN AL MENOS DOS ANTICUERPOS DIFERENTES. LOS METODOS SON UTILES PARA LA DIAGNOSIS DE ENFERMEDADES PANCREATICAS, ESPECIALMENTE PANCREATITIS.
ES95929116T 1994-08-26 1995-08-24 Determinacion de tripsinogeno-2 libre y en forma de complejo. Expired - Lifetime ES2168378T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI943921A FI100557B (fi) 1994-08-26 1994-08-26 Vapaan trypsinogeeni-2:n määritys

Publications (1)

Publication Number Publication Date
ES2168378T3 true ES2168378T3 (es) 2002-06-16

Family

ID=8541252

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95929116T Expired - Lifetime ES2168378T3 (es) 1994-08-26 1995-08-24 Determinacion de tripsinogeno-2 libre y en forma de complejo.

Country Status (9)

Country Link
US (1) US5976809A (es)
EP (1) EP0777860B1 (es)
JP (1) JP3522764B2 (es)
AT (1) ATE209359T1 (es)
DE (1) DE69524107T2 (es)
DK (1) DK0777860T3 (es)
ES (1) ES2168378T3 (es)
FI (1) FI100557B (es)
WO (1) WO1996007104A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11466080B2 (en) 2017-03-22 2022-10-11 Children's Medical Center Corporation Methods of treating cancer using anti-LRP1 polyclonal antibodies
AU2018240306A1 (en) * 2017-03-22 2019-10-10 Children's Medical Center Corporation PRSS2 inhibition
JP7355140B2 (ja) * 2022-02-28 2023-10-03 住友ベークライト株式会社 セリンプロテアーゼの検出用または測定用試薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016575A1 (de) * 1980-04-30 1981-11-05 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur immunologischen bestimmung von enzymen, mittel zur durchfuehrung des verfahrens und seine verwandung
DE3172143D1 (en) * 1980-09-30 1985-10-10 Cornell Res Foundation Inc Process for determining inhibitor-enzyme complexes

Also Published As

Publication number Publication date
EP0777860A1 (en) 1997-06-11
DE69524107D1 (de) 2002-01-03
DE69524107T2 (de) 2002-06-06
ATE209359T1 (de) 2001-12-15
FI943921A (fi) 1996-02-27
DK0777860T3 (da) 2002-05-21
FI943921A0 (fi) 1994-08-26
FI100557B (fi) 1997-12-31
EP0777860B1 (en) 2001-11-21
WO1996007104A1 (en) 1996-03-07
JP3522764B2 (ja) 2004-04-26
JPH10504902A (ja) 1998-05-12
US5976809A (en) 1999-11-02

Similar Documents

Publication Publication Date Title
DE69322860D1 (de) Antikörper gegen alpha v beta 3 integrin
AU2002229970B2 (en) Urine assay for ovarian reserve
DK0540573T4 (da) Assay for frit- og kompleksbundet prostataspecifikt antigen (PSA)
ATE326484T1 (de) Monoklonaler antikörper gegen flt4-rezeptor- tyrosinkinase und dessen verwendung zur diagnose und therapie
AU2002229970A1 (en) Urine assay for ovarian reserve
ES2070488T5 (es) Procedimiento para la diagnosis de enfermedades tumorales.
ATE78601T1 (de) Test fuer menschlichen brustkrebs.
ES2168378T3 (es) Determinacion de tripsinogeno-2 libre y en forma de complejo.
FI973418A0 (fi) Vasta-ainetuotannon toteaminen
DE69530432T2 (de) Monoklonaler Antikörper gegen den Thrombin-Antithrombin Komplex-III und dessen Verwendung in immunoassays
DE59602091D1 (de) Verwendung von polyklonalen humanen anti-htg-autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
WO1990008956A1 (fr) Detection d'activateur de facteur tissulaire humain
KR890702040A (ko) 요중의 염기성 태아단백의 측정방법 및 그것에 사용되는 측정키트
RU93015117A (ru) Способ определения "группы риска" рецидива лепры
EP1947459A3 (en) Differential immunoassay

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 777860

Country of ref document: ES